Estimation models for the morbidity of the horses infected with equine influenza virus.
Abstract: Estimation formulas for the morbidity of horses infected with equine influenza virus by linear regression, logistic regression and probit transformation were developed, using data from the outbreak at the Sha Tin Racing Track in Hong Kong in 1992. Using these formulas, we estimated the equine influenza virus morbidity rates at training centers belonging to the Japan Racing Association (JRA) in October 1997 and in October 1998. In 1998 JRA started a new vaccination program, and every horse must now be vaccinated twice per year. At that time, the vaccine included two US lineage virus strains, the A/equine/Kentucky/81 strain and the A/equine/La Plata/93 (LP93) strain, against equine type-2 influenza viruses; it did not include any EU lineage virus strains, such as A/equine/Suffolk/89 (SF89). Comparing the geometric mean (GM) values of hemagglutination inhibition (HI) titers between the LP93 strain and the SF89 strain in 1997 and in 1998, they both rose significantly at every age (p<0.05) by Wilcoxon test. Calculations by the simulation models show the morbidity rates for LP93 diminished from 0.439 (linear), 0.423 (logistic) and 0.431 (probit) to 0.276 (linear), 0.265 (logistic) and 0.271 (probit), respectively. On the other hand, the estimated morbidity rates for SF89 diminished only slightly from 0.954 (linear), 0.932 (logistic) and 0.944 (probit) to 0.946 (linear), 0.914 (logistic) and 0.927 (probit), respectively. Our simulation models could estimate the effect of the vaccine on each of the equine virus strains represented by the morbidity of infected horses. Thus, they are useful for vaccine evaluation.
Publication Date: 2008-10-24 PubMed ID: 24833957PubMed Central: PMC4013945DOI: 10.1294/jes.19.63Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research is about creating estimation models to understand the severity or prevalence (morbidity) of equine influenza virus in horses. These models were developed using data from a 1992 outbreak and applied to evaluate a new vaccination program started in 1998 by the Japan Racing Association.
Overview of the Research
- The research aimed to develop estimation models to predict the morbidity of horses infected with the equine influenza virus. The researchers used linear regression, logistic regression, and probit transformation models to make these estimations.
Data Collection
- The researchers used data from an outbreak at the Sha Tin Racing Track in Hong Kong in 1992 to develop their estimation models. They then applied these models to estimate morbidity rates at training centers belonging to the Japan Racing Association (JRA) in October 1997 and in October 1998.
- In 1998, the JRA began a new vaccination program in which every horse must be vaccinated twice a year. The vaccine used included two US lineage virus strains, which did not include any EU lineage virus strains.
Simulation Models and Results
- The researchers compared the geometric mean (GM) values of hemagglutination inhibition (HI) titers for two virus strains in 1997 and 1998. Both of these GM values rose significantly indicating an increase in the level of antibodies in the horse’s blood which in turn suggests increased immunity.
- Their calculations showed that morbidity rates for one of the strains (LP93) diminished significantly across all estimation models. However, for the second strain (SF89), the estimated morbidity rates diminished only slightly.
Conclusion of the Study
- The researchers concluded that their simulation models could estimate the effect of the vaccine on each of the equine virus strains through the morbidity rates of infected horses, demonstrating their potential usefulness in vaccine evaluation.
Cite This Article
APA
Sugita S, Oki H, Hasegawa T, Ishida N.
(2008).
Estimation models for the morbidity of the horses infected with equine influenza virus.
J Equine Sci, 19(3), 63-66.
https://doi.org/10.1294/jes.19.63 Publication
Researcher Affiliations
- Laboratory of Molecular and Cellular Biology, Equine Research Institute, Japan Racing Association, 321-4 Tokami-cho, Utsunomiya 320-0856, Japan.
- Laboratory of Molecular and Cellular Biology, Equine Research Institute, Japan Racing Association, 321-4 Tokami-cho, Utsunomiya 320-0856, Japan.
- Laboratory of Molecular and Cellular Biology, Equine Research Institute, Japan Racing Association, 321-4 Tokami-cho, Utsunomiya 320-0856, Japan.
- Laboratory of Molecular and Cellular Biology, Equine Research Institute, Japan Racing Association, 321-4 Tokami-cho, Utsunomiya 320-0856, Japan.
References
This article includes 13 references
- Endo A, Pecoraro R, Sugita S, Nerome K. Evolutionary pattern of the H 3 haemagglutinin of equine influenza viruses: multiple evolutionary lineages and frozen replication.. Arch Virol 1992;123(1-2):73-87.
- InternationalnCollating Center UK. 1996–2000. (ed. Keishuba Boueki Kyougikai).nKeiboukyou news, Tokyo (in Japanese). URL: http://www.equinst.go.jp/keibokyo-homepage/worldinfo/info.index.html
- Lai AC, Lin YP, Powell DG, Shortridge KF, Webster RG, Daly J, Chambers TM. Genetic and antigenic analysis of the influenza virus responsible for the 1992 Hong Kong equine influenza epizootic.. Virology 1994 Nov 1;204(2):673-9.
- Lindstrom S, Endo A, Pecoraro M, Sugita S, Hiromoto Y, Nerome K. Genetic divergency of equine (H3N8) influenza viruses: cocirculation of earliest and recent strains. Proc. 7th Int. Conf. Equine Inf. Dis. 1994;p. 88.
- Lindstrom S, Endo A, Sugita S, Pecoraro M, Hiromoto Y, Kamada M, Takahashi T, Nerome K. Phylogenetic analyses of the matrix and non-structural genes of equine influenza viruses.. Arch Virol 1998;143(8):1585-98.
- Ozaki H, Shimizu-Nei A, Sugita S, Sugiura T, Imagawa H, Kida H. Antigenic variation among equine H 3 N 8 influenza virus hemagglutinins.. Jpn J Vet Res 2001 Feb;48(4):177-86.
- Park AW, Wood JL, Newton JR, Daly J, Mumford JA, Grenfell BT. Optimising vaccination strategies in equine influenza.. Vaccine 2003 Jun 20;21(21-22):2862-70.
- Powell DG, Watkins KL, Li PH, Shortridge KF. Outbreak of equine influenza among horses in Hong Kong during 1992.. Vet Rec 1995 May 27;136(21):531-6.
- SAS Institute Inc. The NLIN Procedure. SAS/STAT User’s Guide, Version 8 Volume 2 2000;pp. 2373–2418.
- SAS Institute Inc. The NPAR1WAY Procedure. SAS/STAT User’s Guide, Version 8 Volume 2 2000;pp. 2505–2552.
- SAS Institute Inc. The PROBIT Procedure. SAS/STAT User’s Guide, Version 8 Volume 3 2000;pp. 2833–2574.
- SAS Institute Inc. The REG Procedure. SAS/STAT User’s Guide, Version 8 Volume 3 2000;pp. 2873–3028.
- Yates P, Mumford JA. Equine influenza vaccine efficacy: the significance of antigenic variation.. Vet Microbiol 2000 May 22;74(1-2):173-7.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists